Drug Safety Monitoring Board

A Drug Safety Monitoring Board (DSMB) is an independent group of experts that reviews data from clinical trials to ensure a drug’s safety for participants. They monitor for any serious side effects or risks that could harm patients and decide if the trial should continue, be modified, or stopped. Their goal is to protect participants and ensure the drug’s benefits outweigh its risks. By regularly assessing the data, DSMBs help ensure clinical trials are conducted ethically and safely, ultimately supporting the development of effective and safe medications.